Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriers

One of three Polish residents has contact allergy (Gell and Coombs type IV hypersensitivity reaction). The most frequent clinical manifestation of contact allergy is allergic contact dermatitis (ACD), affecting approximately one of 10 Poles ever in life, while 1 of a 100 has the symptoms at present....

Full description

Saved in:
Bibliographic Details
Main Authors: Roman Nowicki, Magdalena Czarnecka-Operacz, Elżbieta Grubska-Suchanek, Marta Kieć-Świerczyńska, Cezary Kowalewski, Beata Kręcisz, Jerzy Kruszewski, Maciej Kupczyk, Cezary Pałczyński, Jacek Szepietowski, Magdalena Trzeciak, Jolanta Walusiak-Skorupa, Radosław Śpiewak
Format: Article
Language:English
Published: Termedia Publishing House 2024-08-01
Series:Alergologia Polska
Subjects:
Online Access:https://www.termedia.pl/Position-statement-of-the-Polish-Society-of-Allergology-and-Polish-Dermatological-Society-regarding-the-limited-accessibility-of-materials-necessary-for-patch-testing-Part-I-Technological-and-legal-ba,123,54718,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584868495622144
author Roman Nowicki
Magdalena Czarnecka-Operacz
Elżbieta Grubska-Suchanek
Marta Kieć-Świerczyńska
Cezary Kowalewski
Beata Kręcisz
Jerzy Kruszewski
Maciej Kupczyk
Cezary Pałczyński
Jacek Szepietowski
Magdalena Trzeciak
Jolanta Walusiak-Skorupa
Radosław Śpiewak
author_facet Roman Nowicki
Magdalena Czarnecka-Operacz
Elżbieta Grubska-Suchanek
Marta Kieć-Świerczyńska
Cezary Kowalewski
Beata Kręcisz
Jerzy Kruszewski
Maciej Kupczyk
Cezary Pałczyński
Jacek Szepietowski
Magdalena Trzeciak
Jolanta Walusiak-Skorupa
Radosław Śpiewak
author_sort Roman Nowicki
collection DOAJ
description One of three Polish residents has contact allergy (Gell and Coombs type IV hypersensitivity reaction). The most frequent clinical manifestation of contact allergy is allergic contact dermatitis (ACD), affecting approximately one of 10 Poles ever in life, while 1 of a 100 has the symptoms at present. Cases of allergic reactions to implanted medical devices are also on the rise, causing failures of endoprostheses, implants, insulin pumps, pacemakers and vascular stents. At present, the only validated method and a gold standard of detecting type IV allergy are patch tests. The number of known haptens that can induce contact allergy amounts to 5200 and is still growing. Therefore, state-of-the art allergy and dermatology diagnosis requires patients’ access to a large number of diagnostic haptens. Contrary to the needs, legal regulations introduced in the EU hamper the accessibility to diagnostic haptens. This overregulation endangers citizens’ rights to state-of-the-art healthcare which may undermine the trust of citizens toward public institution in Poland and the EU. In the present position statement, experts of the Polish Society of Allergology and Polish Dermatological Society emphasize the gravity of the present situation and appeal for a partnership debate between competent authorities in the EU and Poland, allergy and dermatology medical societies, as well as patients’ organizations to find a best way of ensuring citizens’ access to necessary allergy diagnosis. First of all, the experts plea for urgent removal of bureaucratic barriers that limit the availability of diagnostic haptens that are indispensable in the state-of-the-art allergy and dermatology care.
format Article
id doaj-art-73a51b3fde1e49248f68fc374ff07d4d
institution Kabale University
issn 2353-3854
2391-6052
language English
publishDate 2024-08-01
publisher Termedia Publishing House
record_format Article
series Alergologia Polska
spelling doaj-art-73a51b3fde1e49248f68fc374ff07d4d2025-01-27T10:34:54ZengTermedia Publishing HouseAlergologia Polska2353-38542391-60522024-08-0111319521010.5114/pja.2024.14269854718Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriersRoman NowickiMagdalena Czarnecka-OperaczElżbieta Grubska-SuchanekMarta Kieć-ŚwierczyńskaCezary KowalewskiBeata KręciszJerzy KruszewskiMaciej KupczykCezary PałczyńskiJacek SzepietowskiMagdalena TrzeciakJolanta Walusiak-SkorupaRadosław ŚpiewakOne of three Polish residents has contact allergy (Gell and Coombs type IV hypersensitivity reaction). The most frequent clinical manifestation of contact allergy is allergic contact dermatitis (ACD), affecting approximately one of 10 Poles ever in life, while 1 of a 100 has the symptoms at present. Cases of allergic reactions to implanted medical devices are also on the rise, causing failures of endoprostheses, implants, insulin pumps, pacemakers and vascular stents. At present, the only validated method and a gold standard of detecting type IV allergy are patch tests. The number of known haptens that can induce contact allergy amounts to 5200 and is still growing. Therefore, state-of-the art allergy and dermatology diagnosis requires patients’ access to a large number of diagnostic haptens. Contrary to the needs, legal regulations introduced in the EU hamper the accessibility to diagnostic haptens. This overregulation endangers citizens’ rights to state-of-the-art healthcare which may undermine the trust of citizens toward public institution in Poland and the EU. In the present position statement, experts of the Polish Society of Allergology and Polish Dermatological Society emphasize the gravity of the present situation and appeal for a partnership debate between competent authorities in the EU and Poland, allergy and dermatology medical societies, as well as patients’ organizations to find a best way of ensuring citizens’ access to necessary allergy diagnosis. First of all, the experts plea for urgent removal of bureaucratic barriers that limit the availability of diagnostic haptens that are indispensable in the state-of-the-art allergy and dermatology care.https://www.termedia.pl/Position-statement-of-the-Polish-Society-of-Allergology-and-Polish-Dermatological-Society-regarding-the-limited-accessibility-of-materials-necessary-for-patch-testing-Part-I-Technological-and-legal-ba,123,54718,1,1.htmlpatch tests diagnostic haptens legal barriers european law polish law medical devices
spellingShingle Roman Nowicki
Magdalena Czarnecka-Operacz
Elżbieta Grubska-Suchanek
Marta Kieć-Świerczyńska
Cezary Kowalewski
Beata Kręcisz
Jerzy Kruszewski
Maciej Kupczyk
Cezary Pałczyński
Jacek Szepietowski
Magdalena Trzeciak
Jolanta Walusiak-Skorupa
Radosław Śpiewak
Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriers
Alergologia Polska
patch tests
diagnostic haptens
legal barriers
european law
polish law
medical devices
title Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriers
title_full Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriers
title_fullStr Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriers
title_full_unstemmed Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriers
title_short Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Technological and legal barriers
title_sort position statement of the polish society of allergology and polish dermatological society regarding the limited accessibility of materials necessary for patch testing part i technological and legal barriers
topic patch tests
diagnostic haptens
legal barriers
european law
polish law
medical devices
url https://www.termedia.pl/Position-statement-of-the-Polish-Society-of-Allergology-and-Polish-Dermatological-Society-regarding-the-limited-accessibility-of-materials-necessary-for-patch-testing-Part-I-Technological-and-legal-ba,123,54718,1,1.html
work_keys_str_mv AT romannowicki positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT magdalenaczarneckaoperacz positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT elzbietagrubskasuchanek positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT martakiecswierczynska positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT cezarykowalewski positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT beatakrecisz positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT jerzykruszewski positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT maciejkupczyk positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT cezarypałczynski positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT jacekszepietowski positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT magdalenatrzeciak positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT jolantawalusiakskorupa positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers
AT radosławspiewak positionstatementofthepolishsocietyofallergologyandpolishdermatologicalsocietyregardingthelimitedaccessibilityofmaterialsnecessaryforpatchtestingpartitechnologicalandlegalbarriers